Last week, Bayer announced it will successfully close the joint venture created between Leaps by Bayer and Ginkgo Bioworks in 2017. And moving forward, Ginkgo Bioworks will become a multi-year microbial strategic partner with Bayer. This will focus on biological solutions in nitrogen optimization, carbon sequestration, next generation crop protection, and more.Read more
Ginkgo Bioworks, a horizontal platform for cell programming, has announced plans to expand its agricultural biologicals capabilities from discovery to field.
These capabilities will be built through a series of transactions, in which Ginkgo will acquire Bayer's 175,000-square-foot West Sacramento Biologics Research and Development site, team, and internal discovery and lead optimization platform as well as integrate the research and development platform assets from Joyn Bio, a joint venture between Ginkgo and Leaps by Bayer, the company's venture capital arm, formed in 2017.Read more
- The shares of Ginkgo Bioworks (NYSE:DNA) are trading higher in the premarket Friday after the cell programming company announced a partnership with German conglomerate Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) to expand its horizontal platform capabilities in agricultural biologicals. The transaction expected to close before the end of 2022 is designed to “support agricultural biologicals R&D from discovery through formulation and early field trials and will offer services to customers of all sizes in the agriculture industry,” Ginkgo (DNA) said.
Bayer is stepping up its game in the agricultural biological space. The firm announced that it is:
- Pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer’s West Sacramento Biologics Research & Development (R&D) site and internal discovery and lead optimization platform. The contemplated transaction, projected to close before the end of 2022 pending final negotiation of the agreement terms and subject to regulatory approvals, will bring Joyn Bio’s nitrogen-fixing technologies to Bayer.
- Closing the joint venture created between Leaps by Bayer and Ginkgo Bioworks in 2017.
Bayer AG and biotech company Ginkgo Bioworks Holdings Inc. will partner to develop products like more environmentally-friendly nitrogen fertilizer and weedkillers. To do that, they’ll collaborate on advancing the use of microbes in agriculture.
The move comes as agribusinesses like Bayer try to find alternatives to chemical pesticides and man-made fertilizers, with farmers increasingly under pressure to switch to more sustainable practices. Fertilizer runoff from farms can enter rivers and streams and hurt water quality. At the same time, pests and diseases are becoming more resistant to current synthetic chemicals.Read more
Bayer to create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms
Bayer today announced that the company is pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer’s West Sacramento Biologics Research & Development (R&D) site and internal discovery and lead optimization platform. The contemplated transaction, projected to close before the end of 2022 pending final negotiation of the agreement terms and subject to regulatory approvals, would also bring Joyn Bio’s nitrogen-fixing technologies to Bayer, successfully closing the joint venture created between Leaps by Bayer and Ginkgo Bioworks in 2017. Ginkgo Bioworks will become a multi-year microbial strategic partner with Bayer in their work to develop biological solutions in fields like nitrogen optimization, carbon sequestration, and next generation crop protection.Read more
Ginkgo Bioworks to Expand Platform Capabilities in Agricultural Biologicals and Launch Flagship Partnership with Bayer
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from discovery to field. These capabilities will be built through a series of transactions, in which Ginkgo will acquire Bayer's 175,000-square-foot West Sacramento Biologics Research & Development site, team, and internal discovery and lead optimization platform as well as integrate the R&D platform assets from Joyn Bio, a joint-venture between Ginkgo and Leaps by Bayer formed in 2017. Bayer will be the anchor agricultural customer of Ginkgo's expanded platform, entering into a significant new multi-year collaboration which will focus on the advancement of Joyn's marquee nitrogen fixation program, as well as new programs in areas such as crop protection and carbon sequestration.Read more
The acceptance of the trendy microbiome diet among consumers has put wind in the sails of ag-biotech start up Joyn Bio, which is engineering microbes for more sustainable agriculture.Read more
In 2018 we used an estimated 117 million tons of nitrogen in the form of fertilizers. The main source of this fertilizer is the Haber process, an industrial chemical reaction that takes place under high pressure and temperature, and requires the consumption of natural gas. Given that 78% of atmospheric air is molecular nitrogen, this seems like a terrible misuse of resources. The problem is that plants cannot use nitrogen directly from the atmosphere, but extract it from the soil in the form of nitrates or ammonia.Read more
Microbes play a crucial role in farming—good bacteria can help plant growth, while bad fungi can decimate crops. Some companies are engineering microbes to both protect plants and enhance growth. “We’re really at a renaissance time for microbial products,” said Brynne Stanton, co-founder of Joyn Bio, at a panel about microbes at the summit.Read more
Biotechnology is accelerating. Nowhere is this more evident than in the frontier of synthetic biology, which views DNA as a programming language for creating new goods like petroleum-free plastics, spider silk jackets and perfumes with the aroma of extinct flowers.Read more
Through the partnership, Joyn Bio will get access to a catalog of thousands of different microbe strains, as well as NewLeaf’s manufacturing capabilities. The deal could significantly benefit Bayer AG, which owns 50 percent of Joyn Bio...Read more
Joyn Bio, a joint venture of Ginkgo Bioworks and agriculture giant Bayer, has brought on another partner in its quest to develop microbes that fix nitrogen for crops. It has turned to NewLeaf Symbiotics for its database of pink, methanol-munching, plant-colonizing organisms.Read more
Biologics hold substantial promise for a more sustainable food system, but with millions of microbes to sort through, startups are turning to partnerships to hunt for the most promising strains in the bacterial haystack.Read more
Joyn Bio, a biotech company developing microbes engineered for agricultural applications, is adding microbes from NewLeaf Symbiotics to its toolbox in an effort to get to market faster and expand the scope of its research.
The partnership announced Monday gives Joyn access to NewLeaf’s library of plant-colonizing microbes. Joyn, which is based in Boston and also has operations in Woodland, CA, will engineer these microbes to make disease and pest control products intended to help farmers reduce their reliance on crop chemicals. In the nearer term, the deal is expected to bolster Joyn’s research and development of nitrogen-fixing microbes. The companies estimate the alliance could reduce the time to market for these new microbes by two to three years.Read more
When I wrote about genetically modified organisms (GMOs) a few months ago (Here's The Real Reason Why GMOs Are Bad, And Why They May Save Humanity, GMOs And The Dangers Of Politicizing Science), I had no idea that the reader response would be so swift and strong.Read more
For the 55% of humans who live in cities, it can be easy to forget just how much of our planet is dedicated to agriculture. More than one-third of all the land on Earth is used to raise the food we eat, and of that, an area nearly the size of Australia is dedicated to growing cereal crops alone. As a species, we are nearly completely dependent on plants for our survival, which are in turn at the mercy of their environment — too much rain, too little sun, too many insects, or the arrival of a new virus can wipe out an entire harvest.Read more
Farmers in the US Midwest, faced with a wet spring, saw their to-do lists lengthen and their time to get everything done shorten. The first week of May should have been the height of planting season. But at that point in Indiana, just a tiny fraction of farm fields had been planted.Read more
Ag-biotech company Joyn Bio has signed a long-term lease to locate its plant sciences team within Bayer’s Vegetable Seed Facility in Woodland, California to accelerate ongoing research. In addition, the company has appointed Bayer Head of Research and Development for Crop Science, Dr. Robert Reiter, to its board of directors.Read more
Joyn Bio, a joint agtech venture between synthetic biology company Ginkgo Bioworks and Bayer, plans to open a research facility in California to speed up the development of its engineered microbes. The aim: fix nitrogen in soil for wheat and corn fields, reducing or even eliminating the need for synthetic fertilizers.Read more
The well-funded ag-tech startup Joyn Bio is expanding into research lab and office space owned by Bayer Group near Woodland.
At the end of June, Boston-based Joyn will move into 12,500 square feet of lab, office and greenhouse space on Bayer’s former Monsanto seeds research lab near Woodland, allowing Joyn’s West Coast team to expand.Read more
Designer microbes could replace the chemical fertilizers that contribute to climate change.Read more
A partnership between Bayer and organism design company Ginkgo Bioworks–the winner of the food category of Fast Company’s 2018 World Changing Ideas Awards–wants to create plants that don’t need energy-hungry, water-polluting nitrogen fertilizerRead more
Joyn Bio was founded with the goal of bringing advanced techniques in synthetic biology to agriculture to support the industry’s sustainability efforts, starting with reducing the environmental impact of nitrogen fertilizer.Read more
“Bayer’s newest biotech startup lab space dedicated to housing and fostering innovative ventures to transform modern agriculture.”
“But these nitrogen-fixing microbes have been limited in what they can do by which plants' evolution has pushed them toward. We’re trying to change that.”Read more
German conglomerate Bayer, together with Boston biotech startup Ginkgo Bioworks, announced this morning that they’re creating a new company that could make it possible for crops like corn, wheat and rice to produce nitrogen fertilizer.Read more